BioNexus Gene Lab (NASDAQ:BGLC) and Applied Visual Sciences (OTCMKTS:APVS) Critical Analysis

BioNexus Gene Lab (NASDAQ:BGLC) and Applied Visual Sciences (OTCMKTS:APVS) are both industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Risk & Volatility

BioNexus Gene Lab has a beta of 4.16, suggesting that its share price is 316% more volatile than the S&P 500. Comparatively, Applied Visual Sciences has a beta of 6.79, suggesting that its share price is 579% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for BioNexus Gene Lab and Applied Visual Sciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1	0	0	0	1.00
Applied Visual Sciences	0	0	0	0	0.00

Given Applied Visual Sciences’ higher probable upside, analysts plainly believe Applied Visual Sciences is more favorable than BioNexus Gene Lab.

Profitability

This table compares BioNexus Gene Lab and Applied Visual Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%
Applied Visual Sciences	N/A	N/A	N/A

Insider and Institutional Ownership

18.9% of BioNexus Gene Lab shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by insiders. Comparatively, 33.0% of Applied Visual Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares BioNexus Gene Lab and Applied Visual Sciences”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43 million	0.59	-$2.98 million	($1.26)	-1.19
Applied Visual Sciences	N/A	N/A	N/A	N/A	N/A

Applied Visual Sciences has lower revenue, but higher earnings than BioNexus Gene Lab.

Summary

Applied Visual Sciences beats BioNexus Gene Lab on 6 of the 9 factors compared between the two stocks.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

About Applied Visual Sciences

Applied Visual Sciences, Inc., a software technology company, designs and develops computer-vision detection solutions based on image processing science for aviation/homeland security and healthcare markets. It utilizes imaging technologies and analytics to create integrated information management technology products and services that address problems for corporations and governmental agencies. The company offers PinPoint, an intelligent computer-vision automated target recognition technology for the detection of guns, explosives, and other threat items contained in baggage in the airport environment or for building security applications; and Signature Mapping platform technology for use in the imaging field of diagnostic radiology and pathology. It also provides Signature Mapping Detection System, an automated hardware-software laboratory solution used to operate various infectious disease applications through multi-threaded detection algorithms. In addition, the company offers Signature Mapping Tuberculosis Detection software, an automated hardware and software technology platform; and Signature Mapping Breast Cancer Detection, a breast cancer detection solution. Applied Visual Sciences, Inc. markets its products through direct sales and indirect distribution channels worldwide. The company was formerly known as Guardian Technologies International, Inc. and changed its name to Applied Visual Sciences, Inc. in July 2010. Applied Visual Sciences, Inc. was founded in 1989 and is based in Leesburg, Virginia.